PRTA - Prothena Corporation PLC Quarterly EPS earnings growth
Prothena Corporation (PRTA) success relies on progress in treating amyloidosis and Alzheimer's, while business resilience is bolstered by alliances with major pharmaceutical companies. The quarterly EPS growth profile confirms the current trend, where the value is maintained at 53.00. Prothena Corporation (PRTA) focuses on developing antibodies to clear tissues of pathological proteins, which defines its long-term development strategy.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_PRTA_-_Prothena-Corporation_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "Prothena Corp (PRTA): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/14/2026 | 👁️GURU.Markets👁️")
Prothena Corporation (PRTA) - metric breakdowns and financial figures
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
- earnings and market multiples details:
PRTA - Profit After Tax|Expected Profit Prothena Corporation|PRTA - Market Cap to Earnings|Future Price to Earnings Prothena Corporation PLC|PRTA - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Prothena Corp|PRTA - Operating profit EBITDA|Net earnings per share for the last 12 months Prothena|PRTA - Earnings per share for the last four quarters|Quarterly EPS earnings growth prothena.com|PRTA - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Prothena Corporation
- company sales and revenue statistics:
Basic company analysis:Prothena Corporation
Quarterly EPS growth reflects the percentage change in net income per share over the last three months. Professionals utilize this metric to assess business scaling rates and sustainability. By analyzing the quarterly EPS growth efficiency indicator, an investor separates the fundamental trend from market volatility. Profit dynamics confirm the commercial value of the Prothena Corporation (PRTA) targeted antibody platform. Strong pricing power in the amyloidosis treatment segment ensures the long-term growth potential of this indicator.
Analysis of competing companies
BIIB: Quarterly EPS earnings growth|Neurocrine - Year-over-year earnings per one share growth for the last 12 months|RGC (Regencell) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Axsome Corp AXSM|Year-over-year earnings per share growth for the last twelve months ACADIA Pharmaceuticals (ACAD)|xenon-pharma.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth VKTX (Viking Therapeutics, Inc.)|Quarterly EPS earnings growth Supernus Pharmaceuticals, Inc. SUPN|CPRX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months DNLI (Denali Corp)|HRMY: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months biohavenpharma.com|Year-over-year earnings per share growth for the last twelve months Amylyx Pharmaceuticals, Inc.|Earnings per share growth in annualized terms for the last twelve months Trevi Therapeutics Inc TRVI|Year-over-year earnings per share growth for the last twelve months Praxis Medicines (PRAX)|AVXL (Anavex Life Sciences Corp) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months CeriBell, Inc. CBLL|ALEC (Alector Inc.) - Year-over-year net earnings per share trend for the last twelve months|ANNX - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Omeros Corporation|Neurogene Corp (NGNE) - Year-over-year earnings per share growth for the last twelve months|AC Immune Inc - Year-over-year earnings per one share growth for the last 12 months|VYGR (Voyager Therapeutics) - Quarterly EPS earnings growth|Quarterly EPS earnings growth neumoratx.com|Year-over-year net earnings per share growth for the last 12 months SCLX (Scilex)|Year-over-year earnings per share growth rate for the last twelve months TVGN|Quarterly EPS earnings growth ACOG (Alpha Cognition Inc.)|Year-over-year net earnings per share change for the last twelve months cogrx.com (CGTX)|IKT - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months cassavasciences.com|assertiotx.com (ASRT) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months COYA|Year-over-year earnings per share growth for the last twelve months VistaGen Therapeutics, Inc.|Ovid Rx - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Acumen Pharmaceuticals (ABOS)|CRVO (cervomed.com) - Year-over-year earnings per one share growth for the last 12 months|Alterity Therapeutics Limited - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months CLNN (Clene Inc)|PepGen Corp - Quarterly EPS earnings growth|JUNS - Quarterly EPS earnings growth|Relmada Therapeutics (RLMD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ANVS|GRCE (Grace Therapeutics Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Firefly Neuroscience, Inc. AIFF|Year-over-year net earnings per share growth for the last 12 months KLTO (Klotho Neurosciences Inc)|Quarterly EPS earnings growth neurosense-tx.com (NRSN)|Year-over-year earnings per share growth for the last twelve months Reviva Pharmaceuticals RVPH|Year-over-year earnings per one share growth for the last 12 months MTVA|NRXS - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Helius Medical|passagebio.com (PASG) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months NEUP (Neuphoria Therapeutics)|Year-over-year earnings per share growth for the last twelve months Minerva Neurosciences|ATHA: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Addex Therapeutics Ltd (ADXN)|ALZN - Earnings per share growth in annualized terms for the last twelve months|Cyclerion Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months PTIX (Protagenic Therapeutics Inc.)|Pasithea - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months CRGT (Cortigent, Inc.)|ATXI: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Brainstorm Cell Therapeutics Inc. (BCLI)|Year-over-year earnings per share growth for the last twelve months Cara Therapeutics, Inc|Year-over-year earnings per share growth for the last 12 months CHRO (Chromocell)|Quarterly EPS earnings growth ELYM|Quarterly EPS earnings growth intracellulartherapies.com (ITCI)|Longboard Pharmaceuticals, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months MRNS|NKGen - Quarterly EPS earnings growth|NeuroBo Pharma (NRBO) - Year-over-year net earnings per share growth for the last 12 months|Sage Therapeutics, Inc. (SAGE) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months synaptogen.com (SNPX)|Year-over-year earnings per share growth for the last twelve months Trevena|VIGL: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Anew Medical, Inc. (WENA)|CERE: Year-over-year net earnings per share trend for the last twelve months
